Date post: | 07-May-2015 |
Category: |
Health & Medicine |
Upload: | vr-foundation |
View: | 1,627 times |
Download: | 1 times |
Controversies in
melanoma
Torello LottiDepartment of Dermatologic Sciences
University of Florence, Italy
The International School of Vitiligo & Pigmentary
Disorders
Barcelona, 2-5 November 2011
Controversies in melanoma’s…
- epidemiology: Melanoma epidemic: true or false? - epidemiology: Melanoma epidemic: true or false?
- etiopathogenesis: The role of sun exposure Hormons and melanoma
- etiopathogenesis: The role of sun exposure Hormons and melanoma - diagnosis & treatment: The role of Sentinel Lymph Node Biopsy The role of Contrast Enanched Ultra Sound The role of Electron Paramagnetic Resonance Excisional VS incisional biopsy
- diagnosis & treatment: The role of Sentinel Lymph Node Biopsy The role of Contrast Enanched Ultra Sound The role of Electron Paramagnetic Resonance Excisional VS incisional biopsy
- Epidemiology -
o The presence of a true melanoma epidemic has been a controversial topic for the past
decade.
o A dramatic increase in the incidence of cutaneous malignant melanoma in developed
countries is well documented, but mortality rates have not risen as rapidly.
The “melanoma epidemic theory” has generated much discussion.
Melanoma epidemic: true or false? Melanoma epidemic: true or false?
FAVOURABLE
AUTHORS
They assert there is a
true increase in disease.
FAVOURABLE
AUTHORS
They assert there is a
true increase in disease.
CONTRARY AUTHORS
They argument this is an
apparent phenomenon that may
be explained by multiple biases
and other factors.
CONTRARY AUTHORS
They argument this is an
apparent phenomenon that may
be explained by multiple biases
and other factors.
Erickson C, Driscoll MS. Melanoma epidemic: Facts and controversies. Clinic Dermatol 2010;28(3):281-286.
Florez A, Cruces M. Melanoma epidemic: true or false? Int J Dermatol 2004;43:405-7.
They believe that this
worldwide melanoma
incidence increase
represents a true epidemic
take the statistics at face
value, with the concept
“res ipsa loquitur”.
They believe that this
worldwide melanoma
incidence increase
represents a true epidemic
take the statistics at face
value, with the concept
“res ipsa loquitur”.
FAVOURABLEFAVOURABLE
Rigel DS, Friedman RJ, Kopf AW, et al. Melanoma incidence: if it quacks like a duck. Arch Dermatol 1997;133:656–658
Beddingfield FC, The melanoma epidemic: res ipsa loquitur. Oncologist 2003;8 :459–465
Melanoma epidemic…? Melanoma epidemic…?
They pose multiple explanations for the
incidence data, including:
• length-time bias
• increased surveillance intensity
• diagnostic uncertainty
• medico-legal climate
• data quality
They pose multiple explanations for the
incidence data, including:
• length-time bias
• increased surveillance intensity
• diagnostic uncertainty
• medico-legal climate
• data quality
They believe that this
worldwide melanoma
incidence increase
represents a true epidemic
take the statistics at face
value, with the concept
“res ipsa loquitur”.
They believe that this
worldwide melanoma
incidence increase
represents a true epidemic
take the statistics at face
value, with the concept
“res ipsa loquitur”.
FAVOURABLEFAVOURABLE CONTRARYCONTRARY
LA Glocker-Reis, D Melber, M Krapcho, Editors et al., SEER Cancer Statistics Review, 1975-2005, National Cancer Institute (2008) Bethesda, MD
Melanoma epidemic…? Melanoma epidemic…?
Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996;34:839-47
Florez A, Cruces M. Melanoma epidemic: true or false? Int J Dermatol 2004;43:405-7.
Schaffer JV, Rigel DS, Kopf AW, et al. Cutaneous melanoma—past, present, and future. J Am Acad Dermatol 2004;51:S65-9.
Rigel DS, Friedman RJ, Kopf AW, et al. Melanoma incidence: if it quacks like a duck. Arch Dermatol 1997;133:656–658
Melanoma epidemic…? Melanoma epidemic…?
In general, the question posed of whether a melanoma
epidemic truly exists has not yet a definitive answer,
because of the absence of randomized controlled trials
which can evaluate the true effect of increased surveillance
and biopsies on mortality rates.
Erickson C, Driscoll MS. Melanoma epidemic: Facts and controversies. Clinic Dermatol 2010;28(3):281-286.
- Etiopathogenesis -
o Despite the evidence of an UV-induced damage to DNA, the exact
relationship between melanoma risk and sun exposure is not yet optimally
known.
Walker G. Cutaneous melanoma: how does ultraviolet light contribute to melanocyte transformation? Future Oncol 2008; 4: 841-56
The role of sun exposure in melanoma The role of sun exposure in melanoma
o Considering mechanisms that allow UV radiations to induce melanoma,
is now generally accepted that the sun exposure is one of the most
relevant risk factor for melanoma.
Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. Int J Dermatol 2010; 49: 978-986
o The controversy lies in the assessment of
what kind of sun exposure, intermittent and
intense versus continuous and gradual,
causes cell degeneration.
Walker G. Cutaneous melanoma: how does ultraviolet light contribute to melanocyte transformation? Future Oncol 2008; 4: 841-56
UVA rays
free radical damage to DNA
immunosuppression: diminishing of the antigen-presenting cell
function
modulation of hypersensitivity reactions
facilitation of immunosuppressive
cytokines
contribute to 10-20% of all UV ray effects UVB rays
erythema, tanning, sunburn, photoaging
carcinogenic effect
DNA damages: formation of cyclobutane pyrimidine
dimers and6-4 photoproducts genetic transitions
(cysteine to thymine)
mutations to p53 gene
UV radiation effects UV radiation effects
o Stratospheric ozone thinning has permitted that an increased
number of rays, mainly the more carcinogenetic UVB, reach the earth’s
surface.
1% of ozone layer’s depletion ccauses to an increase of 1-2% in
melanoma mortality o Altitude and latitude role:
• 1000 meters in elevation correspond to an increase of UV intensity
of 10%
• incidence rates for melanoma correlate with latitude.
Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. Int J Dermatol 2010; 49: 978-986
UV radiation effects UV radiation effects
o Patient-related factors making patients more or less susceptible to UV effects:
• pigmentation features
• melanocyte proliferative response
• DNA repair capability
• cutaneous microenvironmental capacity in contrasting
the proliferation of first mutated melanocytes.
Gradual and continuous
exposure can play a
protective role for the
photoexposed persons.
Gradual and continuous
exposure can play a
protective role for the
photoexposed persons.
Ricceri F. De Giorgi V. Lotti . Melanoma:un’ipotesi eretica relativamente alla fotoesposizione cronica. In: De Giorgi V, Aricò M, Lotti T, eds. Il melanoma. Prevenzione, diagnosi e terapia. Tortona: Fernando Folini; 2008. pp:15-20.
intermittent exposureintermittent exposure
Intermittent, acute and intense
exposure increases the possibility
to develop melanoma and basal
cell carcinoma (BCC).
Intermittent, acute and intense
exposure increases the possibility
to develop melanoma and basal
cell carcinoma (BCC).
Chronic intense UV exposure
is more typically associated
with the squamous cell
carcinoma (SCC) and actinic
keratosis.
Chronic intense UV exposure
is more typically associated
with the squamous cell
carcinoma (SCC) and actinic
keratosis. Among children, melanoma risk
is most associated with
intermittent sunburns.
Among children, melanoma risk
is most associated with
intermittent sunburns.
De Giorgi V, Gori A, Grazzini M et al. Sun exposure and children: what do they know? An observational study in an Italian school. Prev Med 2011; 52: 186-187.
continuous exposurecontinuous exposurevs
It is though to be harmless
for the melanoma.
It is though to be harmless
for the melanoma.
It is defined as “recreational” or
“vacation exposure”: melanoma
often appears in sites not usually
covered by the seasonal habits and
therefore attainable by UVR
It is defined as “recreational” or
“vacation exposure”: melanoma
often appears in sites not usually
covered by the seasonal habits and
therefore attainable by UVR
Moan J, Porojnicu AC, Dahlback A et al. Where the sun does not shine: Is sunshine protective against melanoma of the vulva? J Photochem Photobiol B 2010; 101: 179-183
Benefits of a gradual and continuous sun exposure
Benefits of a gradual and continuous sun exposure
o A correct, gradual and continuous sun
exposure starts a protective, negative-
feedback mechanism which permits to
stimulate melanin and vitamin D production.
Abdel-Malek ZA, Kadekaro AL, Swope VB. Stepping up melanocytes to the challenge of UV exposure. Pigment Cell Melanoma Res 2010; 23: 171-186
Ivry GB, Ogle CA, Shim EK. Role of sun exposure in melanoma. Dermatol Surg 2006; 32: 481-492
Maddodi N, Setaluri V. Role of UV in cutaneous melanoma. Photochem Photobiol 2008; 84: 528-536
has photoprotective properties:
• greater resistance to degradation than pheomelanin
• antioxidant activity direct correlation between eumelanin amount and
catalase levels
• free radicals scavenger preserving DNA from pyrimidine base formation
• filtering and absorbing UV photons and transforming the UV
energy into heat
forming a supranuclear cap between the nucleus and the extracelluar
environment
EumelaninEumelanin
can halt malignant cells’ proliferation, facilitating tissue
differentiation and limiting UV-induced damages.
Vitamin DVitamin D
Benefits of a gradual and continuous sun exposure
Benefits of a gradual and continuous sun exposure
o A correct, gradual and continuous sun
exposure starts a protective, negative-
feedback mechanism which permits to
stimulate melanin and vitamin D production.
Abdel-Malek ZA, Kadekaro AL, Swope VB. Stepping up melanocytes to the challenge of UV exposure. Pigment Cell Melanoma Res 2010; 23: 171-186
Ivry GB, Ogle CA, Shim EK. Role of sun exposure in melanoma. Dermatol Surg 2006; 32: 481-492
Maddodi N, Setaluri V. Role of UV in cutaneous melanoma. Photochem Photobiol 2008; 84: 528-536
o Evidences supporting the hypothesis of a protective role of gradual sun
exposure against melanoma development:
• low melanoma incidence in darker-skinned persons is due to the photoprotection
guaranteed by increased epidermal melanin.
• cutaneous melanoma is more common among indoor workers than in outdoor ones.
• solar elastosis is often associated with better melanoma prognosis and shows an inverse
correlation with melanoma mortality
• there are studies showing a reversed latitude gradient for melanoma
Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol 2008; 58: s129-132
o The question of whether hormones influence melanoma has been
investigated for many years, often leading to inconsistent conclusions.
Hormons and melanoma Hormons and melanoma
o Early case reports of the ‘80s and case series
suggested a negative impact of hormones on the
prognosis of melanoma.
Bain C, Hennekens CH, Speizer FE, et al. Oral contraceptive use and malignant melanoma. J Natl Cancer Inst 1982;68 :537–539.
Holly EA, Weiss NS, Liff JM. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst 1983; 70:827–831.
Beral V, Evans S, Shaw H, et al. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 1984;50 :681–685.
Adam SA, Sheaves SA, Wright NH, et al. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 1981;44 :45–50.
o Some observations had led to
speculation concerning a relationship
between female hormones and
melanoma.
Beral V, Ramcharan S, Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 1977; 36:804–809.
Hormons and melanoma Hormons and melanoma
o Some observations had led to speculation concerning a relationship
between hormones and melanoma.
• melanoma incidence is rare before puberty, rises throughout the
reproductive years until approximately age 50, and then decreases
during menopausal years.
• changes in pigmentation, such as melasma, are associated with
pregnancy, oral contraceptives (OCs), and hormone replacement
therapy (HRT).
• the recently identified estrogen receptor β, has been shown
to be expressed in benign nevi, dysplastic nevi, lentigo maligna,
and melanmas of varying depth.
Strouse JJ, Fears TR,Tucker MA, et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2005;23:4735–4741.
R.P. Gallagher, J.M. Elwood and G.B. Hill, et al. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 1985;52:901–907.
Schmidt A, Nanney LB, Boyd AS, et al. Oestrogen receptor-β expression in melanocytic lesions. Exp Dermatol 2006;15:971–980.
Ohata C,Tadokoro T, Itami S. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas. J Dermatol 2008;35:215–
221.
o Recent clinical studies do not support a deleterious effect of
both exogenous hormones (OCs and HRT) and endogenous
hormones (pregnancy) on melanoma. o According to a recent review of all the controlled studies to
date, OCs and HRT do not appear to increase a woman's risk for
MM; however, there
is more extensive evidence concerning OCs than HRT. Pregnancy
does not appear to influence a woman's risk of melanoma, nor
does
to affect prognosis. Driscoll MS, Grant-Kels JM. Hormones, nevi and melanoma: an approach to the patient. J Am Acad Dermatol 2007;57:919–931.
Kaae J, Andersen A, Boyd HA, et al.Reproductive history and cutaneous malignant melanoma: a comparison between women and men. Am J Epidemiol 2007;165 :1265–1270.
Lea CS, Holly EA, Hartge P, et al. Reproductive risk factors for cutaneous melanoma in women: a case-control study. Am J Epidemiol 2007;165:505–513.
Koomen ER, Joosse A, Herings RM, et al. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol 2009:20,358–564.
Gupta A, Driscoll MS. Do hormones influence melanoma? Facts and controversies. Clin Dermatol 2010;28(3):287-92.
Hormons and melanoma Hormons and melanoma
- Diagnosis &
treatment -
The role of sentinel lymph node biopsyThe role of sentinel lymph node biopsy
o The term “sentinel node”(SN) is used to indicate the lymph node to
which the afferent lymphatic vessels drain first in the regional lymph
node basin.
o SN represents the first lymphatic station which receives
the metastasizing cells coming from the primitive tumour.
Leong SPL, Zuber M, Ferris RL et al. Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol 2011; 103: 518-530
o For this reason, the assessment of the
sentinel node’s histological features allow the
physician to predict the status of the other
neighboring structures of the lymphatic basin.
o Sentinel lymph node biopsy (SLNB) is included in staging guidelines
of the American Joint Committee on Cancer and in treatment guidelines of
the National Comprehensive Cancer Network , and most of the surgical
physicians who treat melanoma adopt it, especially in United States and
Australia.
Ross MI. Sentinel node biopsy for melanoma: An update after two decades of experience.Semin Cutan Med Surg 2010; 29:238-248
o Several studies have confirmed that SLNB is
the most likely site of metastasis, therefore:
• when it is histologically negative, no further
interventions are required
• when it is positive, a complete regional
lymphadenecetomy is suggested because the
other nodes of that lymphatic area probably
contain disease.
The role of sentinel lymph node biopsyThe role of sentinel lymph node biopsy
o An early preoperative assessment of the lymph drainage pattern from
the melanoma can be made through the injection of 99mTc-HSA colloid
and the succeeding lymphoscintigraphyic analysis some hours before
the sentinel node biopsy.
o Combination of the highest radioactivity detected and the presence of
the dye under the incised area, increases the accuracy through which the
physician identifies SN.
From: http://blogs.nejm.org/now/index.php/sentinel-lymph-node-biopsy/2011/05/06/
o The identification of the sentinel
node is permitted also injecting a
blue dye at the tumour site and
visually identifying it later inside the
first draining node.
Gershenwald JE, Ross MI. Sentinel-lymph-node biopsy for cutaneous melanoma.N Engl J Med 2011; 364: 1738-45
Lens M.Sentinel lymph node biopsy in melanoma patients.J Eur Acad Dermatol Venereol 2010; 24: 1005-1012
The role of sentinel lymph node biopsyThe role of sentinel lymph node biopsy
o A limited biopsy of the most likely node is performed rather than a
more invasive removal of the entire regional lymphatic chain.
o SN biopsy is often performed because it provides: - detailed nodal
staging
-
regional disease control
-
possible overall improved survival
o Roughly 20% of melanoma patients show presence of malignant cells’deposits in SN.
o Histopathological examination allows
dermatologist to know:
• the presence of metastasis inside the SN
• relevant features of the metastatic deposit (e.g.,
extension, location, extracapsular spreading
From: http://blogs.nejm.org/now/index.php/sentinel-lymph-node-biopsy/2011/05/06/
Gershenwald JE, Ross MI. Sentinel-lymph-node biopsy for cutaneous melanoma.N Engl J Med 2011; 364: 1738-45
Prieto VG. Sentinel lymph nodes in cutaneous melanoma. Arch Pathol Lab Med 2010; 134: 1764-1769
The role of sentinel lymph node biopsyThe role of sentinel lymph node biopsy
o Mitotic rate has been added by the American Joint Committee on Cancer
to their seventh edition staging system for melanomas, replacing the Clark
level of invasion.
o Otherwise, the exact significance of mitotic rate in melanoma is still
controversial.
o Some author consider it weakly predictive of SN status and argument it
is not an independent predictor of survival for melanomas of 1 mm or
thicker.
o Criteria for SNLB :
• melanoma ≥1 mm in Breslow thickness with no clinically
involved nodes
• melanoma ≥0,75 mm in Breslow thickness with ulceration
• mitotic rate ≥ 1/mm2
Sekula-Gibbs SA, Shearer MA, Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.Dermatol Surg 2011; 37: 1080-8
Roach BA, Burton AL, Mays MP et al.Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?Am J Surg 2010; 200: 759-764
Thompson JF, Shaw HM. Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy?Ann Surg Oncol 2004; 11: 233-5
The role of sentinel lymph node biopsyThe role of sentinel lymph node biopsy
The question whether SNLB influences
positively the overall survival is still the subject
of debate.
All the authors admit the value of SLNB as a
widespread prognostic tool, able to stage patients with
cutaneous melanoma.
To date, a rising part of authors
is sceptical of this position, and
adduces a series of evidences,
which can be summarized
in 5 points.
To date, a rising part of authors
is sceptical of this position, and
adduces a series of evidences,
which can be summarized
in 5 points.
Some authors has argued
in favor of this technique
by postulating that removal
of a SN that resulted
positive at histologic
examination, followed by
lymphadenectomy, has a
therapeutic effect.
Some authors has argued
in favor of this technique
by postulating that removal
of a SN that resulted
positive at histologic
examination, followed by
lymphadenectomy, has a
therapeutic effect.
The role of sentinel lymph node biopsyThe role of sentinel lymph node biopsy
The postulate that all the positive sentinel nodes inevitably
progress to nodal disease is not correct, because it can happen
that some micrometastases in the sentinel node can disappear
for host immune processes or can remain in a dormancy state.
De Giorgi V, Grazzini M, Papi F et al.Sentinel lymph node biopsy: Is it an evolution of the management of cutaneous melanoma?Ann Surg Oncol 2011;18:597
De Giorgi V, Grazzini M, Massi D. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med 2011; 365: 570-571
Thomas JM.Caution with sentinel node biopsy in melanoma.Br J Surg 2006; 93: 129-130
1
22 It has never been shown that the lymphadenectomy performed
after a positive SN finding really improves the survival of
melanoma patients.
Thomas JM. Time to re-evaluate sentinel node biopsy in melanoma postmulticenter selective lymphadenectomy trial. J Clin Oncol 2005; 23: 9443-4
The role of sentinel lymph node biopsyThe role of sentinel lymph node biopsy
The postulate that all the positive SN inevitably progress to
nodal disease is not correct, because it can happen that some
micrometastases in the sentinel node can disappear for host
immune processes or can remain in a dormancy state.
1
22
3
It has never been shown that the lymphadenectomy performed
after a positive SN finding really improves the survival of
melanoma patients.
Results from Multicentre Selective Lymphadenectomy Trials (MSLT-I and II) have
showed that SLNB do not significantly improve overall survival, by comparing the
observation group and the biopsy group, but it helps reducing time for lymph node
metastases detection earlier identification of the natural disease progression
Amersi F, Morton DL.The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg 2007; 41: 241-256
De Giorgi V, Leporatti G, Massi D et al.Sentinel lymph nodes in melanoma patients: evaluating the evidence. Oncology 2006; 71: 460-2
De Giorgi V, Leporatti G, Massi D et al.Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution’s
experience.Oncology 2007; 73: 401-6
The role of sentinel lymph node biopsyThe role of sentinel lymph node biopsy
Melanoma metastatization modalities limits so much the
diagnostical-therapeutical value of SN biopsy, and a following
potential lymphadenectomy.
Indeed, a melanoma can produce:
• cutaneous metastases, satellitosis or in-transit (20% of cases of
initial melanoma)
• regional nodal metastases (50% of cases)
• distant metastases (30%)
In half cases, there could be previous cutaneous and distant metastases not yet
detected at SN biopsy time.
44
The role of sentinel node biopsyThe role of sentinel node biopsy
5
Amersi F, Morton DL.The role of sentinel lymph node biopsy in the management of melanoma. Adv Surg 2007; 41: 241-256
De Giorgi V, Leporatti G, Massi D et al.Sentinel lymph nodes in melanoma patients: evaluating the evidence. Oncology 2006; 71: 460-2
De Giorgi V, Leporatti G, Massi D et al.Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution’s
experience.Oncology 2007; 73: 401-6
SNLB frequently gives false negatives and false positives results.
Van Akkooi ACJ, Voit CA, Verhoef C et al. New developments in sentinel node staging in melanoma: controversies and alternatives.Curr Opin Oncol 2010; 22: 169-177
• malignant cells have not reached the node yet when the sentinel
node is examined, because they are still inside the lymphatic
vessels.
• not all the sentinel nodes are reached by 99mTc-HSA colloid during
the lymphoscintigraphy.
• part of the radiocolloid has cross the sentinel node arriving up to
other nodes, or it could enter inside “second line” bigger nodes.
• there is reduced lymphatic flow to the sentinel node due to the
obstruction by the metastatic bulk.
5 Causes of a possible false negatives result of SLNB techinque:
Van Akkooi ACJ, Voit CA, Verhoef C et al. New developments in sentinel node staging in melanoma: controversies and alternatives.Curr Opin Oncol 2010; 22: 169-177
The role of sentinel node biopsyThe role of sentinel node biopsy
The role of CEUS in melanoma diagnosis The role of CEUS in melanoma diagnosis
o Contrast-enhanced ultrasound system (CEUS) was recently
introduced as an alternative and less invasive procedure, in spite of SLNB, for the
detection of SN.
o Sometimes there is a reduced lymphatic flow to the sentinel node
due to the obstruction given by the metastatic bulk.
o In such cases, using an ultrasound-based evaluation can
successfully identify the node’s involvement.
o CEUS has demonstrated a negative predictive value of 100%,
so that all negative results were confirmed by negative SN
histological examination.
CEUS has shown an high diagnostic accuracy in detecting
occult non-palpable metastases in regional lymph nodes.
De Giorgi V, Gori A, Grazzini M, et al. Contrast-enhanced ultrasound: a filter role in AJCC stage I/II melanoma patients. Oncology 2010; 79: 370-5.
Catalano O, Setola SV, Vallone P, et al. Sonography for locoregional staging and follow-up of cutaneous melanoma: how we do it. J Ultrasound Med 2010;29(5):791-802.
o Electron paramagnetic resonance (EPR) has been recently
employed to melanoma field, because of its ability to detect free radicals
trapped in melanin pigments by using their paramagnetic properties.
o EPR can localize melanoma metastases with high precision and
can help assessing the contribution of UV rays to the initiation of
melanoma.
o EPR spectrometry and imaging largely improve the detection and
mapping of melanin pigments inside ex vivo and in vivo melanomas.
o However, this method has some limitations, and further investigations
are needed.
The role of EPR in melanoma diagnosis The role of EPR in melanoma diagnosis
Melanoma mtx in the lungs of mice and the
respective 2D transversal EPR image.
Godechal Q, Gallez B. The contribution of electron paramagnetic resonance to melanoma research. J Skin Cancer 2011;2011:273-280.
Godechal Q, Defresne F, Danhier P. Assessment of melanoma extent and melanoma metastases invasion using electron paramagnetic resonance and bioluminescence imaging. Contrast Media Mol Imaging 2011;6(4):282-8.
o Whereas the surgical excision is accepted world wide as primary treatment for
melanoma, the prognostic significance of incisional bopsy is discussed controversially,
and so far, no international consensus has been reached.
o Incisional biopsies are currently recommended for the histopathologic diagnosis of
large tumors in facial, mucosal, and acral locations.
o Evidence from latest trials and studies is that incisional biopsies of malignant
melanoma are not associated with an unfavorable prognosis for patients.
o Anyway, complete excision of primary melanoma is still the recommended standard of
care and is a precondition for accurate histopathologic diagnosis.
Excisional VS incisional biopsyExcisional VS incisional biopsy
Pflugfelder A, Weide B, Eigentler TK. Incisional biopsy and melanoma prognosis: Facts and controversies. Clin Dermatol 2010;28(3):316-8.
Leiter U, Eigentler TK, Forschner A, et al. Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversies. Clin Dermatol. 2010 ;28(3):311-5.
From: http://www.glowm.com/resources/glowm/cd/pages/v1/v1c011.html?SESSID=cvrcbl8q7c00h40nmlti9r0na3
Cutaneous melanoma is an emerging and complex
health problem.
Management may require the expertise of multiple
specialties.
Although the outlook for advanced disease remains
very poor, there are major advances in the understanding
of melanoma.
As technology improves and information continues to
accrue, our increased understanding of melanoma will
lead to improved treatment of advanced disease.
Take home messagesTake home messages